Lawmaker Challenges Legality of $2 Billion Quantum Funding Under CHIPS Act

TL;DR: Lawmaker Zoe Lofgren says the $2 billion quantum-computing investment violates the CHIPS Act's semiconductor focus, calling the deals illegal and troubling.

The CHIPS and Science Act, enacted in 2022, earmarked about $52 billion for domestic semiconductor research, manufacturing, and workforce development. Congress framed the money as a way to shore up the microelectronics supply chain and support R&D directly tied to chip technology. Quantum computing, which processes information with qubits rather than classical bits, is still largely experimental and not yet a mainstream chip product.

The administration launched a $2 billion initiative that allocates $100 million in equity to each of roughly two dozen quantum startups, giving the government a minority stake in exchange for capital. Representative Zoe Lofgren (D-Calif.), ranking member of the House Science, Space, and Technology Committee, said the funding is illegal because the CHIPS Act's appropriations were limited to microelectronics R&D centered on semiconductor technology.

She added that the deals do not constitute the public-private research partnerships the act envisioned. In a related move, the firm Anderon will receive $1 billion from IBM and $1 billion from the government, acquiring IBM's personnel and IP to run a foundry that fabricates quantum processing units and sells access to IBM and other firms.

If Lofgren's challenge prompts a GAO review or congressional hearing, the administration may need to justify the spending under a broader interpretation of the act or seek new appropriations. The debate underscores the difficulty of applying legislation written for traditional semiconductors to next-generation computing technologies that share only partial overlap in materials and processes.

Should the funding be deemed unlawful, the equity stakes in the startups could be unwound, and the Anderon foundry plan might be delayed or restructured pending a legal determination. Conversely, if the administration prevails, it could set a precedent for using CHIPS Act money to back other emerging fields such as advanced photonics or neuromorphic chips.

Watch for a potential congressional oversight hearing or GAO report in the coming months that will clarify whether the quantum investments comply with the CHIPS Act's statutory language.